Cargando…
Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents
The identification of dystrophin and the causative role of mutations in this gene in Duchenne and Becker muscular dystrophies (D/BMD) was expected to lead to timely development of effective therapies. Despite over 20 years of research, corticosteroids remain the only available pharmacological treatm...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681176/ https://www.ncbi.nlm.nih.gov/pubmed/23776365 http://dx.doi.org/10.2147/TACG.S8762 |